China Universal Asset Management Co., Ltd. Allogene Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 40,219 shares of ALLO stock, worth $98,938. This represents 0.01% of its overall portfolio holdings.
Number of Shares
40,219
Previous 24,529
63.97%
Holding current value
$98,938
Previous $57,000
96.49%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ALLO
# of Institutions
162Shares Held
134MCall Options Held
59.4KPut Options Held
113K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$46 Million1.25% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$40.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$20.5 Million0.0% of portfolio
-
State Street Corp Boston, MA7.01MShares$17.3 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.9MShares$17 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $354M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...